nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—osteoarthritis—Prednisone—prostate cancer	0.4	1	CpDpCtD
Diflunisal—PTGS2—prostate cancer	0.128	1	CbGaD
Diflunisal—ALB—Abiraterone—prostate cancer	0.0582	0.26	CbGbCtD
Diflunisal—ALB—Estrone—prostate cancer	0.0421	0.188	CbGbCtD
Diflunisal—SLC22A6—Conjugated Estrogens—prostate cancer	0.0323	0.144	CbGbCtD
Diflunisal—PTGS2—Etoposide—prostate cancer	0.025	0.112	CbGbCtD
Diflunisal—ALB—Estradiol—prostate cancer	0.0242	0.108	CbGbCtD
Diflunisal—PTGS1—Etoposide—prostate cancer	0.0211	0.0945	CbGbCtD
Diflunisal—ALB—Prednisone—prostate cancer	0.0208	0.0929	CbGbCtD
Diflunisal—TTR—urine—prostate cancer	0.00488	0.293	CbGeAlD
Diflunisal—UGT1A8—renal system—prostate cancer	0.0026	0.156	CbGeAlD
Diflunisal—Niclosamide—STAT3—prostate cancer	0.00173	0.525	CrCbGaD
Diflunisal—TTR—renal system—prostate cancer	0.00119	0.0716	CbGeAlD
Diflunisal—TTR—bone marrow—prostate cancer	0.000903	0.0542	CbGeAlD
Diflunisal—TTR—testis—prostate cancer	0.000772	0.0463	CbGeAlD
Diflunisal—PTGS1—prostate gland—prostate cancer	0.000638	0.0382	CbGeAlD
Diflunisal—PTGS2—prostate gland—prostate cancer	0.000609	0.0365	CbGeAlD
Diflunisal—PTGS1—seminal vesicle—prostate cancer	0.000539	0.0323	CbGeAlD
Diflunisal—PTGS2—seminal vesicle—prostate cancer	0.000515	0.0309	CbGeAlD
Diflunisal—ALB—testis—prostate cancer	0.000493	0.0296	CbGeAlD
Diflunisal—PTGS1—epithelium—prostate cancer	0.000469	0.0281	CbGeAlD
Diflunisal—PTGS2—epithelium—prostate cancer	0.000448	0.0269	CbGeAlD
Diflunisal—Aminosalicylic Acid—MPO—prostate cancer	0.000438	0.133	CrCbGaD
Diflunisal—PTGS1—renal system—prostate cancer	0.000435	0.0261	CbGeAlD
Diflunisal—PTGS2—renal system—prostate cancer	0.000415	0.0249	CbGeAlD
Diflunisal—PTGS2—urethra—prostate cancer	0.000408	0.0245	CbGeAlD
Diflunisal—ALB—lymph node—prostate cancer	0.000357	0.0214	CbGeAlD
Diflunisal—Mesalazine—MPO—prostate cancer	0.000344	0.104	CrCbGaD
Diflunisal—PTGS2—bone marrow—prostate cancer	0.000314	0.0188	CbGeAlD
Diflunisal—PTGS1—testis—prostate cancer	0.000281	0.0168	CbGeAlD
Diflunisal—PTGS1—lymph node—prostate cancer	0.000204	0.0122	CbGeAlD
Diflunisal—PTGS2—lymph node—prostate cancer	0.000195	0.0117	CbGeAlD
Diflunisal—Olsalazine—PTGS2—prostate cancer	0.000175	0.0529	CrCbGaD
Diflunisal—Aminosalicylic Acid—PTGS2—prostate cancer	0.000164	0.0497	CrCbGaD
Diflunisal—Salsalate—PTGS2—prostate cancer	0.000148	0.0449	CrCbGaD
Diflunisal—Mesalazine—PTGS2—prostate cancer	0.000129	0.039	CrCbGaD
Diflunisal—Muscle spasms—Docetaxel—prostate cancer	9.27e-05	0.000768	CcSEcCtD
Diflunisal—Flatulence—Capecitabine—prostate cancer	9.2e-05	0.000762	CcSEcCtD
Diflunisal—Nausea—Goserelin—prostate cancer	9.16e-05	0.000759	CcSEcCtD
Diflunisal—Hyperhidrosis—Etoposide—prostate cancer	9.16e-05	0.000759	CcSEcCtD
Diflunisal—Salicylic acid—PTGS2—prostate cancer	9.13e-05	0.0276	CrCbGaD
Diflunisal—Nausea—Conjugated Estrogens—prostate cancer	9.07e-05	0.000751	CcSEcCtD
Diflunisal—Urticaria—Mitoxantrone—prostate cancer	9.05e-05	0.000749	CcSEcCtD
Diflunisal—Anorexia—Etoposide—prostate cancer	9.03e-05	0.000748	CcSEcCtD
Diflunisal—Hypersensitivity—Estradiol—prostate cancer	9e-05	0.000746	CcSEcCtD
Diflunisal—Body temperature increased—Mitoxantrone—prostate cancer	9e-05	0.000746	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	9e-05	0.000746	CcSEcCtD
Diflunisal—Muscle spasms—Capecitabine—prostate cancer	8.98e-05	0.000744	CcSEcCtD
Diflunisal—Flushing—Prednisone—prostate cancer	8.87e-05	0.000735	CcSEcCtD
Diflunisal—Gastritis—Doxorubicin—prostate cancer	8.85e-05	0.000733	CcSEcCtD
Diflunisal—Vision blurred—Capecitabine—prostate cancer	8.8e-05	0.000729	CcSEcCtD
Diflunisal—Asthenia—Estradiol—prostate cancer	8.77e-05	0.000726	CcSEcCtD
Diflunisal—Dysuria—Epirubicin—prostate cancer	8.73e-05	0.000723	CcSEcCtD
Diflunisal—Syncope—Docetaxel—prostate cancer	8.65e-05	0.000717	CcSEcCtD
Diflunisal—Pruritus—Estradiol—prostate cancer	8.65e-05	0.000716	CcSEcCtD
Diflunisal—Palpitations—Docetaxel—prostate cancer	8.52e-05	0.000706	CcSEcCtD
Diflunisal—Photosensitivity reaction—Epirubicin—prostate cancer	8.52e-05	0.000706	CcSEcCtD
Diflunisal—Paraesthesia—Etoposide—prostate cancer	8.51e-05	0.000705	CcSEcCtD
Diflunisal—Loss of consciousness—Docetaxel—prostate cancer	8.48e-05	0.000702	CcSEcCtD
Diflunisal—Dyspnoea—Etoposide—prostate cancer	8.45e-05	0.0007	CcSEcCtD
Diflunisal—Somnolence—Etoposide—prostate cancer	8.42e-05	0.000698	CcSEcCtD
Diflunisal—Vertigo—Capecitabine—prostate cancer	8.39e-05	0.000695	CcSEcCtD
Diflunisal—Hypersensitivity—Mitoxantrone—prostate cancer	8.39e-05	0.000695	CcSEcCtD
Diflunisal—Syncope—Capecitabine—prostate cancer	8.38e-05	0.000694	CcSEcCtD
Diflunisal—Diarrhoea—Estradiol—prostate cancer	8.36e-05	0.000693	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Epirubicin—prostate cancer	8.25e-05	0.000684	CcSEcCtD
Diflunisal—Palpitations—Capecitabine—prostate cancer	8.25e-05	0.000684	CcSEcCtD
Diflunisal—Decreased appetite—Etoposide—prostate cancer	8.23e-05	0.000682	CcSEcCtD
Diflunisal—Chest pain—Docetaxel—prostate cancer	8.21e-05	0.00068	CcSEcCtD
Diflunisal—Loss of consciousness—Capecitabine—prostate cancer	8.21e-05	0.00068	CcSEcCtD
Diflunisal—Renal failure—Epirubicin—prostate cancer	8.18e-05	0.000678	CcSEcCtD
Diflunisal—Asthenia—Mitoxantrone—prostate cancer	8.17e-05	0.000677	CcSEcCtD
Diflunisal—Fatigue—Etoposide—prostate cancer	8.17e-05	0.000676	CcSEcCtD
Diflunisal—Jaundice—Epirubicin—prostate cancer	8.12e-05	0.000672	CcSEcCtD
Diflunisal—Stomatitis—Epirubicin—prostate cancer	8.12e-05	0.000672	CcSEcCtD
Diflunisal—Constipation—Etoposide—prostate cancer	8.1e-05	0.000671	CcSEcCtD
Diflunisal—Dizziness—Estradiol—prostate cancer	8.08e-05	0.000669	CcSEcCtD
Diflunisal—Dysuria—Doxorubicin—prostate cancer	8.08e-05	0.000669	CcSEcCtD
Diflunisal—Flurbiprofen—PTGS2—prostate cancer	8.01e-05	0.0242	CrCbGaD
Diflunisal—Sweating—Epirubicin—prostate cancer	7.98e-05	0.000661	CcSEcCtD
Diflunisal—Chest pain—Capecitabine—prostate cancer	7.95e-05	0.000659	CcSEcCtD
Diflunisal—Haematuria—Epirubicin—prostate cancer	7.94e-05	0.000658	CcSEcCtD
Diflunisal—Confusional state—Docetaxel—prostate cancer	7.94e-05	0.000658	CcSEcCtD
Diflunisal—Photosensitivity reaction—Doxorubicin—prostate cancer	7.89e-05	0.000653	CcSEcCtD
Diflunisal—Anaphylactic shock—Docetaxel—prostate cancer	7.87e-05	0.000652	CcSEcCtD
Diflunisal—Oedema—Docetaxel—prostate cancer	7.87e-05	0.000652	CcSEcCtD
Diflunisal—Vision blurred—Prednisone—prostate cancer	7.84e-05	0.000649	CcSEcCtD
Diflunisal—Feeling abnormal—Etoposide—prostate cancer	7.81e-05	0.000647	CcSEcCtD
Diflunisal—Diarrhoea—Mitoxantrone—prostate cancer	7.79e-05	0.000645	CcSEcCtD
Diflunisal—Vomiting—Estradiol—prostate cancer	7.77e-05	0.000644	CcSEcCtD
Diflunisal—Agranulocytosis—Epirubicin—prostate cancer	7.77e-05	0.000644	CcSEcCtD
Diflunisal—Gastrointestinal pain—Etoposide—prostate cancer	7.75e-05	0.000642	CcSEcCtD
Diflunisal—Shock—Docetaxel—prostate cancer	7.75e-05	0.000642	CcSEcCtD
Diflunisal—Thrombocytopenia—Docetaxel—prostate cancer	7.71e-05	0.000638	CcSEcCtD
Diflunisal—Rash—Estradiol—prostate cancer	7.71e-05	0.000638	CcSEcCtD
Diflunisal—Dermatitis—Estradiol—prostate cancer	7.7e-05	0.000638	CcSEcCtD
Diflunisal—Confusional state—Capecitabine—prostate cancer	7.69e-05	0.000637	CcSEcCtD
Diflunisal—Headache—Estradiol—prostate cancer	7.66e-05	0.000634	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	7.64e-05	0.000633	CcSEcCtD
Diflunisal—Oedema—Capecitabine—prostate cancer	7.62e-05	0.000631	CcSEcCtD
Diflunisal—Angioedema—Prednisone—prostate cancer	7.6e-05	0.00063	CcSEcCtD
Diflunisal—Renal failure—Doxorubicin—prostate cancer	7.57e-05	0.000627	CcSEcCtD
Diflunisal—Urticaria—Etoposide—prostate cancer	7.53e-05	0.000623	CcSEcCtD
Diflunisal—Stomatitis—Doxorubicin—prostate cancer	7.51e-05	0.000622	CcSEcCtD
Diflunisal—Jaundice—Doxorubicin—prostate cancer	7.51e-05	0.000622	CcSEcCtD
Diflunisal—Anorexia—Docetaxel—prostate cancer	7.5e-05	0.000622	CcSEcCtD
Diflunisal—Shock—Capecitabine—prostate cancer	7.5e-05	0.000621	CcSEcCtD
Diflunisal—Body temperature increased—Etoposide—prostate cancer	7.49e-05	0.00062	CcSEcCtD
Diflunisal—Vertigo—Prednisone—prostate cancer	7.47e-05	0.000619	CcSEcCtD
Diflunisal—Hepatitis—Epirubicin—prostate cancer	7.47e-05	0.000619	CcSEcCtD
Diflunisal—Thrombocytopenia—Capecitabine—prostate cancer	7.46e-05	0.000618	CcSEcCtD
Diflunisal—Syncope—Prednisone—prostate cancer	7.46e-05	0.000618	CcSEcCtD
Diflunisal—Sweating—Doxorubicin—prostate cancer	7.39e-05	0.000612	CcSEcCtD
Diflunisal—Hyperhidrosis—Capecitabine—prostate cancer	7.37e-05	0.00061	CcSEcCtD
Diflunisal—Haematuria—Doxorubicin—prostate cancer	7.35e-05	0.000608	CcSEcCtD
Diflunisal—Loss of consciousness—Prednisone—prostate cancer	7.31e-05	0.000606	CcSEcCtD
Diflunisal—Anorexia—Capecitabine—prostate cancer	7.27e-05	0.000602	CcSEcCtD
Diflunisal—Nausea—Estradiol—prostate cancer	7.26e-05	0.000601	CcSEcCtD
Diflunisal—Vomiting—Mitoxantrone—prostate cancer	7.24e-05	0.0006	CcSEcCtD
Diflunisal—Visual impairment—Epirubicin—prostate cancer	7.2e-05	0.000597	CcSEcCtD
Diflunisal—Agranulocytosis—Doxorubicin—prostate cancer	7.19e-05	0.000595	CcSEcCtD
Diflunisal—Rash—Mitoxantrone—prostate cancer	7.18e-05	0.000595	CcSEcCtD
Diflunisal—Dermatitis—Mitoxantrone—prostate cancer	7.17e-05	0.000594	CcSEcCtD
Diflunisal—Headache—Mitoxantrone—prostate cancer	7.13e-05	0.000591	CcSEcCtD
Diflunisal—Insomnia—Docetaxel—prostate cancer	7.12e-05	0.00059	CcSEcCtD
Diflunisal—Paraesthesia—Docetaxel—prostate cancer	7.07e-05	0.000586	CcSEcCtD
Diflunisal—Erythema multiforme—Epirubicin—prostate cancer	7.07e-05	0.000585	CcSEcCtD
Diflunisal—Dyspnoea—Docetaxel—prostate cancer	7.02e-05	0.000581	CcSEcCtD
Diflunisal—Somnolence—Docetaxel—prostate cancer	7e-05	0.00058	CcSEcCtD
Diflunisal—Hypersensitivity—Etoposide—prostate cancer	6.98e-05	0.000578	CcSEcCtD
Diflunisal—Tinnitus—Epirubicin—prostate cancer	6.97e-05	0.000577	CcSEcCtD
Diflunisal—Flushing—Epirubicin—prostate cancer	6.94e-05	0.000575	CcSEcCtD
Diflunisal—Dyspepsia—Docetaxel—prostate cancer	6.93e-05	0.000574	CcSEcCtD
Diflunisal—Hepatitis—Doxorubicin—prostate cancer	6.92e-05	0.000573	CcSEcCtD
Diflunisal—Insomnia—Capecitabine—prostate cancer	6.89e-05	0.000571	CcSEcCtD
Diflunisal—Paraesthesia—Capecitabine—prostate cancer	6.84e-05	0.000567	CcSEcCtD
Diflunisal—Decreased appetite—Docetaxel—prostate cancer	6.84e-05	0.000567	CcSEcCtD
Diflunisal—Asthenia—Etoposide—prostate cancer	6.8e-05	0.000563	CcSEcCtD
Diflunisal—Dyspnoea—Capecitabine—prostate cancer	6.8e-05	0.000563	CcSEcCtD
Diflunisal—Anaphylactic shock—Prednisone—prostate cancer	6.79e-05	0.000562	CcSEcCtD
Diflunisal—Oedema—Prednisone—prostate cancer	6.79e-05	0.000562	CcSEcCtD
Diflunisal—Fatigue—Docetaxel—prostate cancer	6.79e-05	0.000562	CcSEcCtD
Diflunisal—Nausea—Mitoxantrone—prostate cancer	6.76e-05	0.00056	CcSEcCtD
Diflunisal—Constipation—Docetaxel—prostate cancer	6.73e-05	0.000558	CcSEcCtD
Diflunisal—Dyspepsia—Capecitabine—prostate cancer	6.71e-05	0.000556	CcSEcCtD
Diflunisal—Pruritus—Etoposide—prostate cancer	6.7e-05	0.000555	CcSEcCtD
Diflunisal—Shock—Prednisone—prostate cancer	6.68e-05	0.000553	CcSEcCtD
Diflunisal—Visual impairment—Doxorubicin—prostate cancer	6.66e-05	0.000552	CcSEcCtD
Diflunisal—Decreased appetite—Capecitabine—prostate cancer	6.63e-05	0.000549	CcSEcCtD
Diflunisal—Fatigue—Capecitabine—prostate cancer	6.57e-05	0.000544	CcSEcCtD
Diflunisal—Hyperhidrosis—Prednisone—prostate cancer	6.56e-05	0.000544	CcSEcCtD
Diflunisal—Erythema multiforme—Doxorubicin—prostate cancer	6.54e-05	0.000542	CcSEcCtD
Diflunisal—Constipation—Capecitabine—prostate cancer	6.52e-05	0.00054	CcSEcCtD
Diflunisal—Feeling abnormal—Docetaxel—prostate cancer	6.49e-05	0.000537	CcSEcCtD
Diflunisal—Diarrhoea—Etoposide—prostate cancer	6.48e-05	0.000537	CcSEcCtD
Diflunisal—Anorexia—Prednisone—prostate cancer	6.47e-05	0.000536	CcSEcCtD
Diflunisal—Tinnitus—Doxorubicin—prostate cancer	6.45e-05	0.000534	CcSEcCtD
Diflunisal—Gastrointestinal pain—Docetaxel—prostate cancer	6.44e-05	0.000533	CcSEcCtD
Diflunisal—Flushing—Doxorubicin—prostate cancer	6.42e-05	0.000532	CcSEcCtD
Diflunisal—Flatulence—Epirubicin—prostate cancer	6.41e-05	0.000531	CcSEcCtD
Diflunisal—Tension—Epirubicin—prostate cancer	6.38e-05	0.000529	CcSEcCtD
Diflunisal—Nervousness—Epirubicin—prostate cancer	6.32e-05	0.000523	CcSEcCtD
Diflunisal—Feeling abnormal—Capecitabine—prostate cancer	6.28e-05	0.00052	CcSEcCtD
Diflunisal—Dizziness—Etoposide—prostate cancer	6.26e-05	0.000519	CcSEcCtD
Diflunisal—Muscle spasms—Epirubicin—prostate cancer	6.26e-05	0.000518	CcSEcCtD
Diflunisal—Gastrointestinal pain—Capecitabine—prostate cancer	6.23e-05	0.000516	CcSEcCtD
Diflunisal—Body temperature increased—Docetaxel—prostate cancer	6.22e-05	0.000515	CcSEcCtD
Diflunisal—Insomnia—Prednisone—prostate cancer	6.14e-05	0.000509	CcSEcCtD
Diflunisal—Vision blurred—Epirubicin—prostate cancer	6.13e-05	0.000508	CcSEcCtD
Diflunisal—Paraesthesia—Prednisone—prostate cancer	6.1e-05	0.000505	CcSEcCtD
Diflunisal—Urticaria—Capecitabine—prostate cancer	6.06e-05	0.000502	CcSEcCtD
Diflunisal—Body temperature increased—Capecitabine—prostate cancer	6.03e-05	0.000499	CcSEcCtD
Diflunisal—Vomiting—Etoposide—prostate cancer	6.02e-05	0.000499	CcSEcCtD
Diflunisal—Dyspepsia—Prednisone—prostate cancer	5.98e-05	0.000495	CcSEcCtD
Diflunisal—Rash—Etoposide—prostate cancer	5.97e-05	0.000495	CcSEcCtD
Diflunisal—Dermatitis—Etoposide—prostate cancer	5.97e-05	0.000494	CcSEcCtD
Diflunisal—Headache—Etoposide—prostate cancer	5.93e-05	0.000492	CcSEcCtD
Diflunisal—Flatulence—Doxorubicin—prostate cancer	5.93e-05	0.000491	CcSEcCtD
Diflunisal—Tension—Doxorubicin—prostate cancer	5.91e-05	0.000489	CcSEcCtD
Diflunisal—Decreased appetite—Prednisone—prostate cancer	5.9e-05	0.000489	CcSEcCtD
Diflunisal—Fatigue—Prednisone—prostate cancer	5.85e-05	0.000485	CcSEcCtD
Diflunisal—Nervousness—Doxorubicin—prostate cancer	5.85e-05	0.000484	CcSEcCtD
Diflunisal—Vertigo—Epirubicin—prostate cancer	5.85e-05	0.000484	CcSEcCtD
Diflunisal—Syncope—Epirubicin—prostate cancer	5.83e-05	0.000483	CcSEcCtD
Diflunisal—Constipation—Prednisone—prostate cancer	5.81e-05	0.000481	CcSEcCtD
Diflunisal—Hypersensitivity—Docetaxel—prostate cancer	5.8e-05	0.00048	CcSEcCtD
Diflunisal—Muscle spasms—Doxorubicin—prostate cancer	5.79e-05	0.000479	CcSEcCtD
Diflunisal—Palpitations—Epirubicin—prostate cancer	5.75e-05	0.000476	CcSEcCtD
Diflunisal—Loss of consciousness—Epirubicin—prostate cancer	5.72e-05	0.000474	CcSEcCtD
Diflunisal—Vision blurred—Doxorubicin—prostate cancer	5.67e-05	0.00047	CcSEcCtD
Diflunisal—Asthenia—Docetaxel—prostate cancer	5.65e-05	0.000468	CcSEcCtD
Diflunisal—Nausea—Etoposide—prostate cancer	5.63e-05	0.000466	CcSEcCtD
Diflunisal—Hypersensitivity—Capecitabine—prostate cancer	5.62e-05	0.000465	CcSEcCtD
Diflunisal—Feeling abnormal—Prednisone—prostate cancer	5.59e-05	0.000463	CcSEcCtD
Diflunisal—Pruritus—Docetaxel—prostate cancer	5.57e-05	0.000461	CcSEcCtD
Diflunisal—Gastrointestinal pain—Prednisone—prostate cancer	5.55e-05	0.00046	CcSEcCtD
Diflunisal—Chest pain—Epirubicin—prostate cancer	5.54e-05	0.000459	CcSEcCtD
Diflunisal—Asthenia—Capecitabine—prostate cancer	5.47e-05	0.000453	CcSEcCtD
Diflunisal—Vertigo—Doxorubicin—prostate cancer	5.41e-05	0.000448	CcSEcCtD
Diflunisal—Syncope—Doxorubicin—prostate cancer	5.4e-05	0.000447	CcSEcCtD
Diflunisal—Urticaria—Prednisone—prostate cancer	5.39e-05	0.000447	CcSEcCtD
Diflunisal—Pruritus—Capecitabine—prostate cancer	5.39e-05	0.000447	CcSEcCtD
Diflunisal—Diarrhoea—Docetaxel—prostate cancer	5.39e-05	0.000446	CcSEcCtD
Diflunisal—Body temperature increased—Prednisone—prostate cancer	5.37e-05	0.000445	CcSEcCtD
Diflunisal—Confusional state—Epirubicin—prostate cancer	5.35e-05	0.000443	CcSEcCtD
Diflunisal—Palpitations—Doxorubicin—prostate cancer	5.32e-05	0.000441	CcSEcCtD
Diflunisal—Anaphylactic shock—Epirubicin—prostate cancer	5.31e-05	0.00044	CcSEcCtD
Diflunisal—Oedema—Epirubicin—prostate cancer	5.31e-05	0.00044	CcSEcCtD
Diflunisal—Loss of consciousness—Doxorubicin—prostate cancer	5.29e-05	0.000438	CcSEcCtD
Diflunisal—Shock—Epirubicin—prostate cancer	5.22e-05	0.000433	CcSEcCtD
Diflunisal—Diarrhoea—Capecitabine—prostate cancer	5.22e-05	0.000432	CcSEcCtD
Diflunisal—Dizziness—Docetaxel—prostate cancer	5.21e-05	0.000431	CcSEcCtD
Diflunisal—Thrombocytopenia—Epirubicin—prostate cancer	5.2e-05	0.000431	CcSEcCtD
Diflunisal—Hyperhidrosis—Epirubicin—prostate cancer	5.13e-05	0.000425	CcSEcCtD
Diflunisal—Chest pain—Doxorubicin—prostate cancer	5.13e-05	0.000425	CcSEcCtD
Diflunisal—Anorexia—Epirubicin—prostate cancer	5.06e-05	0.000419	CcSEcCtD
Diflunisal—Dizziness—Capecitabine—prostate cancer	5.04e-05	0.000417	CcSEcCtD
Diflunisal—Vomiting—Docetaxel—prostate cancer	5.01e-05	0.000415	CcSEcCtD
Diflunisal—Hypersensitivity—Prednisone—prostate cancer	5e-05	0.000414	CcSEcCtD
Diflunisal—Rash—Docetaxel—prostate cancer	4.96e-05	0.000411	CcSEcCtD
Diflunisal—Dermatitis—Docetaxel—prostate cancer	4.96e-05	0.000411	CcSEcCtD
Diflunisal—Confusional state—Doxorubicin—prostate cancer	4.95e-05	0.00041	CcSEcCtD
Diflunisal—Headache—Docetaxel—prostate cancer	4.93e-05	0.000409	CcSEcCtD
Diflunisal—Anaphylactic shock—Doxorubicin—prostate cancer	4.91e-05	0.000407	CcSEcCtD
Diflunisal—Oedema—Doxorubicin—prostate cancer	4.91e-05	0.000407	CcSEcCtD
Diflunisal—Asthenia—Prednisone—prostate cancer	4.87e-05	0.000403	CcSEcCtD
Diflunisal—Vomiting—Capecitabine—prostate cancer	4.85e-05	0.000401	CcSEcCtD
Diflunisal—Shock—Doxorubicin—prostate cancer	4.83e-05	0.0004	CcSEcCtD
Diflunisal—Thrombocytopenia—Doxorubicin—prostate cancer	4.81e-05	0.000398	CcSEcCtD
Diflunisal—Rash—Capecitabine—prostate cancer	4.81e-05	0.000398	CcSEcCtD
Diflunisal—Pruritus—Prednisone—prostate cancer	4.8e-05	0.000398	CcSEcCtD
Diflunisal—Insomnia—Epirubicin—prostate cancer	4.8e-05	0.000398	CcSEcCtD
Diflunisal—Dermatitis—Capecitabine—prostate cancer	4.8e-05	0.000398	CcSEcCtD
Diflunisal—Headache—Capecitabine—prostate cancer	4.77e-05	0.000396	CcSEcCtD
Diflunisal—Paraesthesia—Epirubicin—prostate cancer	4.77e-05	0.000395	CcSEcCtD
Diflunisal—Hyperhidrosis—Doxorubicin—prostate cancer	4.75e-05	0.000393	CcSEcCtD
Diflunisal—Dyspnoea—Epirubicin—prostate cancer	4.73e-05	0.000392	CcSEcCtD
Diflunisal—Somnolence—Epirubicin—prostate cancer	4.72e-05	0.000391	CcSEcCtD
Diflunisal—Anorexia—Doxorubicin—prostate cancer	4.68e-05	0.000388	CcSEcCtD
Diflunisal—Nausea—Docetaxel—prostate cancer	4.68e-05	0.000387	CcSEcCtD
Diflunisal—Dyspepsia—Epirubicin—prostate cancer	4.67e-05	0.000387	CcSEcCtD
Diflunisal—Diarrhoea—Prednisone—prostate cancer	4.65e-05	0.000385	CcSEcCtD
Diflunisal—Decreased appetite—Epirubicin—prostate cancer	4.62e-05	0.000382	CcSEcCtD
Diflunisal—Fatigue—Epirubicin—prostate cancer	4.58e-05	0.000379	CcSEcCtD
Diflunisal—Constipation—Epirubicin—prostate cancer	4.54e-05	0.000376	CcSEcCtD
Diflunisal—Nausea—Capecitabine—prostate cancer	4.53e-05	0.000375	CcSEcCtD
Diflunisal—Dizziness—Prednisone—prostate cancer	4.49e-05	0.000372	CcSEcCtD
Diflunisal—Insomnia—Doxorubicin—prostate cancer	4.44e-05	0.000368	CcSEcCtD
Diflunisal—Paraesthesia—Doxorubicin—prostate cancer	4.41e-05	0.000365	CcSEcCtD
Diflunisal—Dyspnoea—Doxorubicin—prostate cancer	4.38e-05	0.000363	CcSEcCtD
Diflunisal—Feeling abnormal—Epirubicin—prostate cancer	4.38e-05	0.000362	CcSEcCtD
Diflunisal—Somnolence—Doxorubicin—prostate cancer	4.37e-05	0.000362	CcSEcCtD
Diflunisal—Gastrointestinal pain—Epirubicin—prostate cancer	4.34e-05	0.00036	CcSEcCtD
Diflunisal—Dyspepsia—Doxorubicin—prostate cancer	4.32e-05	0.000358	CcSEcCtD
Diflunisal—Vomiting—Prednisone—prostate cancer	4.32e-05	0.000358	CcSEcCtD
Diflunisal—Rash—Prednisone—prostate cancer	4.28e-05	0.000355	CcSEcCtD
Diflunisal—Dermatitis—Prednisone—prostate cancer	4.28e-05	0.000354	CcSEcCtD
Diflunisal—Decreased appetite—Doxorubicin—prostate cancer	4.27e-05	0.000354	CcSEcCtD
Diflunisal—Headache—Prednisone—prostate cancer	4.25e-05	0.000352	CcSEcCtD
Diflunisal—Fatigue—Doxorubicin—prostate cancer	4.24e-05	0.000351	CcSEcCtD
Diflunisal—Urticaria—Epirubicin—prostate cancer	4.22e-05	0.000349	CcSEcCtD
Diflunisal—Constipation—Doxorubicin—prostate cancer	4.2e-05	0.000348	CcSEcCtD
Diflunisal—Body temperature increased—Epirubicin—prostate cancer	4.2e-05	0.000348	CcSEcCtD
Diflunisal—Feeling abnormal—Doxorubicin—prostate cancer	4.05e-05	0.000335	CcSEcCtD
Diflunisal—Nausea—Prednisone—prostate cancer	4.03e-05	0.000334	CcSEcCtD
Diflunisal—Gastrointestinal pain—Doxorubicin—prostate cancer	4.02e-05	0.000333	CcSEcCtD
Diflunisal—Hypersensitivity—Epirubicin—prostate cancer	3.91e-05	0.000324	CcSEcCtD
Diflunisal—Urticaria—Doxorubicin—prostate cancer	3.9e-05	0.000323	CcSEcCtD
Diflunisal—Body temperature increased—Doxorubicin—prostate cancer	3.88e-05	0.000322	CcSEcCtD
Diflunisal—Asthenia—Epirubicin—prostate cancer	3.81e-05	0.000316	CcSEcCtD
Diflunisal—Pruritus—Epirubicin—prostate cancer	3.76e-05	0.000311	CcSEcCtD
Diflunisal—Diarrhoea—Epirubicin—prostate cancer	3.63e-05	0.000301	CcSEcCtD
Diflunisal—Hypersensitivity—Doxorubicin—prostate cancer	3.62e-05	0.0003	CcSEcCtD
Diflunisal—Asthenia—Doxorubicin—prostate cancer	3.53e-05	0.000292	CcSEcCtD
Diflunisal—Dizziness—Epirubicin—prostate cancer	3.51e-05	0.000291	CcSEcCtD
Diflunisal—Pruritus—Doxorubicin—prostate cancer	3.48e-05	0.000288	CcSEcCtD
Diflunisal—Vomiting—Epirubicin—prostate cancer	3.38e-05	0.00028	CcSEcCtD
Diflunisal—Diarrhoea—Doxorubicin—prostate cancer	3.36e-05	0.000278	CcSEcCtD
Diflunisal—Rash—Epirubicin—prostate cancer	3.35e-05	0.000277	CcSEcCtD
Diflunisal—Dermatitis—Epirubicin—prostate cancer	3.34e-05	0.000277	CcSEcCtD
Diflunisal—Headache—Epirubicin—prostate cancer	3.33e-05	0.000276	CcSEcCtD
Diflunisal—Dizziness—Doxorubicin—prostate cancer	3.25e-05	0.000269	CcSEcCtD
Diflunisal—Nausea—Epirubicin—prostate cancer	3.15e-05	0.000261	CcSEcCtD
Diflunisal—Vomiting—Doxorubicin—prostate cancer	3.12e-05	0.000259	CcSEcCtD
Diflunisal—Rash—Doxorubicin—prostate cancer	3.1e-05	0.000257	CcSEcCtD
Diflunisal—Dermatitis—Doxorubicin—prostate cancer	3.09e-05	0.000256	CcSEcCtD
Diflunisal—Headache—Doxorubicin—prostate cancer	3.08e-05	0.000255	CcSEcCtD
Diflunisal—Nausea—Doxorubicin—prostate cancer	2.92e-05	0.000242	CcSEcCtD
Diflunisal—TTR—Disease—MYC—prostate cancer	6.87e-06	6.38e-05	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PIK3CA—prostate cancer	6.86e-06	6.36e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTA1—prostate cancer	6.86e-06	6.36e-05	CbGpPWpGaD
Diflunisal—TTR—Disease—TGFB1—prostate cancer	6.85e-06	6.36e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NQO1—prostate cancer	6.8e-06	6.31e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ERBB2—prostate cancer	6.79e-06	6.3e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—HSD3B2—prostate cancer	6.78e-06	6.29e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTO1—prostate cancer	6.78e-06	6.29e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NAT2—prostate cancer	6.78e-06	6.29e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FGFR4—prostate cancer	6.76e-06	6.27e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PARP1—prostate cancer	6.76e-06	6.27e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CAV1—prostate cancer	6.73e-06	6.25e-05	CbGpPWpGaD
Diflunisal—TTR—Disease—EGFR—prostate cancer	6.72e-06	6.24e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—TH—prostate cancer	6.7e-06	6.22e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CB—prostate cancer	6.7e-06	6.22e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—HPGDS—prostate cancer	6.7e-06	6.21e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CALCA—prostate cancer	6.68e-06	6.19e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.66e-06	6.18e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP2C19—prostate cancer	6.66e-06	6.18e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP3A4—prostate cancer	6.63e-06	6.15e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.6e-06	6.12e-05	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	6.53e-06	6.06e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP1B1—prostate cancer	6.52e-06	6.05e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.52e-06	6.05e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—LRP2—prostate cancer	6.5e-06	6.03e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP2C18—prostate cancer	6.5e-06	6.03e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PLCB2—prostate cancer	6.5e-06	6.03e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ACHE—prostate cancer	6.5e-06	6.03e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTT1—prostate cancer	6.5e-06	6.03e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCL8—prostate cancer	6.44e-06	5.97e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP2A6—prostate cancer	6.42e-06	5.96e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HSPA1A—prostate cancer	6.4e-06	5.94e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.4e-06	5.94e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—P4HB—prostate cancer	6.37e-06	5.91e-05	CbGpPWpGaD
Diflunisal—TTR—Disease—KRAS—prostate cancer	6.35e-06	5.89e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GGT1—prostate cancer	6.31e-06	5.86e-05	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	6.3e-06	5.85e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CDKN1B—prostate cancer	6.29e-06	5.83e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—AKR1C3—prostate cancer	6.25e-06	5.8e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NCOA1—prostate cancer	6.22e-06	5.77e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PRKACB—prostate cancer	6.21e-06	5.77e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC22A1—prostate cancer	6.2e-06	5.75e-05	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	6.2e-06	5.75e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CASP3—prostate cancer	6.16e-06	5.72e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL2—prostate cancer	6.15e-06	5.71e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP17A1—prostate cancer	6.15e-06	5.71e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CASP9—prostate cancer	6.14e-06	5.7e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CG—prostate cancer	6.13e-06	5.69e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP19A1—prostate cancer	6.13e-06	5.69e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.13e-06	5.69e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.07e-06	5.63e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—EGF—prostate cancer	6.06e-06	5.62e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SULT2A1—prostate cancer	6.04e-06	5.61e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCND1—prostate cancer	6e-06	5.57e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PRKCQ—prostate cancer	5.95e-06	5.52e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—MED12—prostate cancer	5.94e-06	5.51e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CTNNB1—prostate cancer	5.94e-06	5.51e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—RXRA—prostate cancer	5.92e-06	5.49e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GNG5—prostate cancer	5.9e-06	5.47e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NCOA2—prostate cancer	5.86e-06	5.44e-05	CbGpPWpGaD
Diflunisal—TTR—Disease—PIK3CA—prostate cancer	5.83e-06	5.41e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MMP9—prostate cancer	5.82e-06	5.4e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CDKN1A—prostate cancer	5.8e-06	5.38e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PTEN—prostate cancer	5.79e-06	5.37e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.75e-06	5.34e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—COMT—prostate cancer	5.7e-06	5.29e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CREBBP—prostate cancer	5.68e-06	5.27e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NCOA3—prostate cancer	5.68e-06	5.27e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTP1—prostate cancer	5.67e-06	5.26e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FGF10—prostate cancer	5.65e-06	5.25e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IGF1—prostate cancer	5.61e-06	5.21e-05	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—AKT1—prostate cancer	5.6e-06	5.2e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SLC5A5—prostate cancer	5.59e-06	5.19e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.58e-06	5.18e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ITPR1—prostate cancer	5.58e-06	5.18e-05	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	5.56e-06	5.16e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EP300—prostate cancer	5.52e-06	5.12e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.49e-06	5.09e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP2E1—prostate cancer	5.46e-06	5.07e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—HPGDS—prostate cancer	5.42e-06	5.03e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NQO1—prostate cancer	5.4e-06	5.01e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CD—prostate cancer	5.39e-06	5e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP2C19—prostate cancer	5.38e-06	5e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TGFBR2—prostate cancer	5.38e-06	4.99e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SRC—prostate cancer	5.37e-06	4.98e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SERPINE1—prostate cancer	5.33e-06	4.95e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—TH—prostate cancer	5.32e-06	4.94e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ITPR1—prostate cancer	5.29e-06	4.91e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.29e-06	4.91e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—TYMS—prostate cancer	5.27e-06	4.89e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP3A4—prostate cancer	5.27e-06	4.89e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTT1—prostate cancer	5.26e-06	4.88e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ACHE—prostate cancer	5.26e-06	4.88e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—VEGFA—prostate cancer	5.23e-06	4.85e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTM1—prostate cancer	5.21e-06	4.84e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP2A6—prostate cancer	5.2e-06	4.82e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—STAT3—prostate cancer	5.18e-06	4.8e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP1B1—prostate cancer	5.18e-06	4.8e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.18e-06	4.8e-05	CbGpPWpGaD
Diflunisal—TTR—Disease—IL6—prostate cancer	5.17e-06	4.79e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—LPL—prostate cancer	5.12e-06	4.75e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—NOS3—prostate cancer	5.09e-06	4.72e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—AKR1C3—prostate cancer	5.05e-06	4.69e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PRKACB—prostate cancer	5.03e-06	4.66e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GGT1—prostate cancer	5.01e-06	4.65e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP17A1—prostate cancer	4.98e-06	4.62e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—JAK2—prostate cancer	4.95e-06	4.59e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP1A1—prostate cancer	4.94e-06	4.58e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NCOA1—prostate cancer	4.94e-06	4.58e-05	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.92e-06	4.57e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.91e-06	4.55e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ERCC2—prostate cancer	4.9e-06	4.55e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP19A1—prostate cancer	4.87e-06	4.52e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—LPL—prostate cancer	4.85e-06	4.5e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MYC—prostate cancer	4.81e-06	4.46e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PDGFRB—prostate cancer	4.81e-06	4.46e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TGFB1—prostate cancer	4.8e-06	4.45e-05	CbGpPWpGaD
Diflunisal—TTR—Disease—AKT1—prostate cancer	4.77e-06	4.42e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NCOA2—prostate cancer	4.74e-06	4.4e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EGFR—prostate cancer	4.71e-06	4.37e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CB—prostate cancer	4.7e-06	4.36e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—RXRA—prostate cancer	4.7e-06	4.36e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ERCC2—prostate cancer	4.65e-06	4.31e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—MTHFR—prostate cancer	4.61e-06	4.27e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.57e-06	4.24e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ERBB3—prostate cancer	4.54e-06	4.22e-05	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	4.54e-06	4.21e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FGFR2—prostate cancer	4.54e-06	4.21e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—COMT—prostate cancer	4.52e-06	4.2e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC5A5—prostate cancer	4.52e-06	4.2e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PPARA—prostate cancer	4.52e-06	4.19e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTP1—prostate cancer	4.5e-06	4.18e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—KRAS—prostate cancer	4.45e-06	4.13e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ITPR1—prostate cancer	4.43e-06	4.11e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP2E1—prostate cancer	4.42e-06	4.1e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NQO1—prostate cancer	4.37e-06	4.05e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MTHFR—prostate cancer	4.37e-06	4.05e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.36e-06	4.04e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TERT—prostate cancer	4.35e-06	4.04e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL2—prostate cancer	4.31e-06	4e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—TH—prostate cancer	4.3e-06	3.99e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.28e-06	3.97e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP3A4—prostate cancer	4.26e-06	3.95e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CAV1—prostate cancer	4.25e-06	3.94e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.24e-06	3.93e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP1B1—prostate cancer	4.19e-06	3.89e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—TYMS—prostate cancer	4.19e-06	3.88e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HIF1A—prostate cancer	4.16e-06	3.86e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTM1—prostate cancer	4.14e-06	3.84e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CA—prostate cancer	4.08e-06	3.79e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—LPL—prostate cancer	4.06e-06	3.77e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.06e-06	3.77e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GGT1—prostate cancer	4.06e-06	3.76e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CAV1—prostate cancer	4.03e-06	3.74e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NCOA1—prostate cancer	4e-06	3.71e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TP53—prostate cancer	3.95e-06	3.67e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP19A1—prostate cancer	3.94e-06	3.65e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP1A1—prostate cancer	3.92e-06	3.64e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ERCC2—prostate cancer	3.89e-06	3.61e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—EP300—prostate cancer	3.87e-06	3.59e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CG—prostate cancer	3.87e-06	3.59e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—RXRA—prostate cancer	3.8e-06	3.53e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—BAD—prostate cancer	3.79e-06	3.51e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SRC—prostate cancer	3.76e-06	3.49e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.7e-06	3.43e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—APC—prostate cancer	3.67e-06	3.4e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—VEGFA—prostate cancer	3.67e-06	3.4e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—INS—prostate cancer	3.66e-06	3.4e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—COMT—prostate cancer	3.66e-06	3.4e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—MTHFR—prostate cancer	3.66e-06	3.39e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTP1—prostate cancer	3.64e-06	3.38e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IRS1—prostate cancer	3.63e-06	3.36e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EGF—prostate cancer	3.63e-06	3.36e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL6—prostate cancer	3.62e-06	3.36e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CREBBP—prostate cancer	3.59e-06	3.33e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PPARA—prostate cancer	3.59e-06	3.33e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ITPR1—prostate cancer	3.58e-06	3.33e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.52e-06	3.27e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—GSK3B—prostate cancer	3.52e-06	3.27e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—INS—prostate cancer	3.47e-06	3.22e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CD—prostate cancer	3.4e-06	3.16e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CREBBP—prostate cancer	3.4e-06	3.16e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—TYMS—prostate cancer	3.39e-06	3.14e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CAV1—prostate cancer	3.37e-06	3.13e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TGFB1—prostate cancer	3.37e-06	3.12e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTM1—prostate cancer	3.35e-06	3.11e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—AKT1—prostate cancer	3.34e-06	3.1e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—LPL—prostate cancer	3.29e-06	3.05e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MAP2K1—prostate cancer	3.25e-06	3.01e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CD—prostate cancer	3.23e-06	2.99e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.22e-06	2.99e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NOS3—prostate cancer	3.21e-06	2.98e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SERPINE1—prostate cancer	3.19e-06	2.96e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP1A1—prostate cancer	3.17e-06	2.94e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ERCC2—prostate cancer	3.15e-06	2.92e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—KRAS—prostate cancer	3.12e-06	2.89e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FGF2—prostate cancer	3.09e-06	2.87e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CG—prostate cancer	3.07e-06	2.85e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NOS3—prostate cancer	3.05e-06	2.83e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CB—prostate cancer	2.97e-06	2.75e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—JAK2—prostate cancer	2.96e-06	2.75e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—MTHFR—prostate cancer	2.96e-06	2.75e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTGS2—prostate cancer	2.94e-06	2.73e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—INS—prostate cancer	2.91e-06	2.7e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PPARA—prostate cancer	2.9e-06	2.69e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MDM2—prostate cancer	2.89e-06	2.68e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CA—prostate cancer	2.86e-06	2.66e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CREBBP—prostate cancer	2.85e-06	2.64e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ERBB2—prostate cancer	2.85e-06	2.64e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CB—prostate cancer	2.81e-06	2.61e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TP53—prostate cancer	2.77e-06	2.57e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CAV1—prostate cancer	2.73e-06	2.53e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CD—prostate cancer	2.7e-06	2.51e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CDKN1B—prostate cancer	2.64e-06	2.45e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.61e-06	2.42e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTEN—prostate cancer	2.56e-06	2.38e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NOS3—prostate cancer	2.55e-06	2.37e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CTNNB1—prostate cancer	2.49e-06	2.31e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CG—prostate cancer	2.49e-06	2.31e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—EP300—prostate cancer	2.44e-06	2.27e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CDKN1A—prostate cancer	2.43e-06	2.26e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PTEN—prostate cancer	2.43e-06	2.25e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CB—prostate cancer	2.35e-06	2.18e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—INS—prostate cancer	2.35e-06	2.18e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—AKT1—prostate cancer	2.34e-06	2.17e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EP300—prostate cancer	2.32e-06	2.15e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CREBBP—prostate cancer	2.3e-06	2.14e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SRC—prostate cancer	2.25e-06	2.09e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CD—prostate cancer	2.19e-06	2.03e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—STAT3—prostate cancer	2.17e-06	2.02e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NOS3—prostate cancer	2.06e-06	1.91e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PTEN—prostate cancer	2.03e-06	1.89e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MYC—prostate cancer	2.02e-06	1.87e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TGFB1—prostate cancer	2.01e-06	1.87e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EGFR—prostate cancer	1.97e-06	1.83e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—EP300—prostate cancer	1.94e-06	1.8e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CB—prostate cancer	1.9e-06	1.77e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTGS2—prostate cancer	1.89e-06	1.75e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—KRAS—prostate cancer	1.87e-06	1.73e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CA—prostate cancer	1.81e-06	1.68e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CA—prostate cancer	1.71e-06	1.59e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTEN—prostate cancer	1.65e-06	1.53e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—EP300—prostate cancer	1.57e-06	1.46e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IL6—prostate cancer	1.52e-06	1.41e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—AKT1—prostate cancer	1.48e-06	1.37e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CA—prostate cancer	1.44e-06	1.33e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—AKT1—prostate cancer	1.4e-06	1.3e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—AKT1—prostate cancer	1.17e-06	1.09e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CA—prostate cancer	1.16e-06	1.08e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—AKT1—prostate cancer	9.49e-07	8.8e-06	CbGpPWpGaD
